Do Investigators Need Their Own Lawyers?

Investigators are often a key to success in the expanding world of collaborations between industry and universities. Yet, unlike the company and the university, the investigator is rarely represented by legal counsel. This is often the case whether the investigator serves as an independent consultant to the company or engages in company-funded research performed at the university. This situation may help to explain why university-industry relationships are plagued with controversies, includi

Written byPhilip Goldman
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Investigators are often a key to success in the expanding world of collaborations between industry and universities. Yet, unlike the company and the university, the investigator is rarely represented by legal counsel. This is often the case whether the investigator serves as an independent consultant to the company or engages in company-funded research performed at the university.

This situation may help to explain why university-industry relationships are plagued with controversies, including those affecting patents and ownership, publications, material exchanges, and increasing secretiveness. Yet the numbers of university-generated patents, licensing transactions, and funded research efforts have increased dramatically over recent years. Though companies and universities are always well represented in these matters, investigators themselves typically rely on the institution's legal counsel, or none at all.

What, if anything, can be done about this? One solution that remains unexplored is legal representation for investigators.

The patent laws themselves form the basis for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies